Safety Notices

From time to time notices relating to the safety, efficacy and quality of human medicinal products are published by the Health Products Regulatory Authority.

The issues covered by these notices include medicinal product safety information, updated efficacy information on the appropriate usage of medicines and quality defect information.

Notices are categorised in accordance with their importance at time of publication.

The four notice categories are outlined as follows:

  • Advisory  -  Routine safety information            
  • Warning  -  Urgent safety information
  • Recall  -  Urgent safety information relating to a product recall
  • Publications  -  General information provided by 3rd parties as approved by the HPRA, e.g. MIMS, Direct Healthcare Professional Letter or Product Information Update

The HPRA Drug Safety Newsletter is also published on a regular basis.

Date Title Type
10/08/2022 Medicinal Product Shortages - update - 10 August 2022 Advisory
03/08/2022 Medicinal Product Shortages - update - 3 August 2022 Advisory
27/07/2022 Medicinal Product Shortages - update - 27 July 2022 Advisory
25/07/2022 Update to safety warnings in product information leaflet for Hiprabovis IBR Marker Live Vaccine Advisory
20/07/2022 Medicinal Product Shortages - update - 20 July 2022 Advisory
13/07/2022 Medicinal Product Shortages - update - 13th July 2022 Advisory
08/07/2022 Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 3rd Party Publications
06/07/2022 Medicinal Product Shortages - update - 6th July 2022 Advisory
29/06/2022 Medicinal Product Shortages – update – 29 June 2022 Advisory
27/06/2022 Risks of using Melanotan 2 Advisory